Patents by Inventor Kirsten M. Cabot

Kirsten M. Cabot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Storage stable powder compositions of interleukin-4 receptor
    Patent number: 7767198
    Abstract: The present invention provides storage stable dry powder compositions of IL-4R. The powder compositions demonstrate superior chemical and physical stability over their solution counterparts, particularly upon storage under varying conditions of temperature and humidity. Moreover, the powders, as prepared, possess good aerosol properties, which are maintained upon storage.
    Type: Grant
    Filed: October 6, 2008
    Date of Patent: August 3, 2010
    Assignee: Novartis AG
    Inventors: Jayne E. Hastedt, Kirsten M. Cabot, David Gong, Dennis M. Hester
  • STORAGE STABLE POWDER COMPOSITIONS OF INTERLEUKIN-4 RECEPTOR
    Publication number: 20090035264
    Abstract: The present invention provides storage stable dry powder compositions of IL-4R. The powder compositions demonstrate superior chemical and physical stability over their solution counterparts, particularly upon storage under varying conditions of temperature and humidity. Moreover, the powders, as prepared, possess good aerosol properties, which are maintained upon storage.
    Type: Application
    Filed: October 6, 2008
    Publication date: February 5, 2009
    Applicant: Nektar Therapeutics
    Inventors: Jayne E. Hastedt, Kirsten M. Cabot, David K. Gong, Dennis M. Hester
  • Storage stable power compositions of interleukin-4 receptor
    Patent number: 7449201
    Abstract: The present invention provides storage stable dry powder compositions of IL-4R. The powder compositions demonstrate superior chemical and physical stability over their solution counterparts, particularly upon storage under varying conditions of temperature and humidity. Moreover, the powders, as prepared, possess good aerosol properties, which are maintained upon storage.
    Type: Grant
    Filed: December 21, 2006
    Date of Patent: November 11, 2008
    Assignee: Nektar Therapeutics
    Inventors: Jayne E. Hastedt, Kirsten M. Cabot, David K. Gong, Dennis M. Hester
  • Storage stable powder compositions of interleukin-4 receptor
    Patent number: 6896906
    Abstract: The present invention provides storage stable dry powder compositions of IL-4R. The powder compositions demonstrate superior chemical and physical stability over their solution counterparts, particularly upon storage under varying conditions of temperature and humidity. Moreover, the powders, as prepared, possess good aerosol properties, which are maintained upon storage.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: May 24, 2005
    Assignee: Nektar Therapeutics
    Inventors: Jayne E. Hastedt, Kirsten M. Cabot, David K. Gong, Dennis M. Hester
  • Liquid crystal forms of cyclosporin
    Publication number: 20030130176
    Abstract: This invention relates to novel, liquid crystal forms of the cyclic peptide cyclosporin and to novel powder formulations of cyclosporin prepared using this novel liquid crystal form of the drug. Methods for preparing and using these formulations are also provided. In particular, the present invention relates to dispersible spray dried particles of cyclosporin suitable for pulmonary delivery.
    Type: Application
    Filed: May 29, 2002
    Publication date: July 10, 2003
    Inventors: David B. Bennett, Kirsten M. Cabot, Linda C. Foster, David Lechuga-Ballesteros, John S. Patton, Trixie K. Tan
  • Storage stable powder compositions of interleukin-4 receptor
    Publication number: 20020176846
    Abstract: The present invention provides storage stable dry powder compositions of IL-4R. The powder compositions demonstrate superior chemical and physical stability over their solution counterparts, particularly upon storage under varying conditions of temperature and humidity. Moreover, the powders, as prepared, possess good aerosol properties, which are maintained upon storage.
    Type: Application
    Filed: December 21, 2001
    Publication date: November 28, 2002
    Inventors: Jayne E. Hastedt, Kirsten M. Cabot, David K. Gong, Dennis M. Hester
  • Liquid crystal forms of cyclosporin
    Patent number: 6413547
    Abstract: This invention relates to novel, liquid crystal forms of the cyclic peptide cyclosporin and to novel powder formulations of cyclosporin prepared using this novel liquid crystal form of the drug. Methods for preparing and using these formulations are also provided. In particular, the present invention relates to dispersible spray dried particles of cyclosporin suitable for pulmonary delivery.
    Type: Grant
    Filed: February 11, 1999
    Date of Patent: July 2, 2002
    Assignee: Inhale Therapeutic Systems, Inc.
    Inventors: David B. Bennett, Kirsten M. Cabot, Linda C. Foster, David Lechuga-Ballesteros, John S. Patton, Trixie K. Tan